Press

Featured Publications

Milasen: The drug that went from idea to injection in 10 months

A custom antisense oligonucleotide drug has set records for both personalization and speed in drug development

Read Now

Rich Horgan of Cure Rare Disease Named to Forbes '30 Under 30' 2021

Recognizing the Nonprofit Biotech Founder’s Leadership in the Groundbreaking Development of Customized Therapeutics to Treat Duchenne Muscular Dystrophy & Other Rare Diseases...

Read Now

Cure Rare Disease’s Rich Horgan Pioneers Customized Medicine to Treat Brother with DMD

Rich Horgan’s younger brother, Terry Horgan, is the inspiration behind Cure Rare Disease...

Read Now

Meet the family working with scientists to fight rare diseases with CRISPR therapy

Terry Horgan, 24, is suffering from a rare form of muscular dystrophy. His brother Richard created a nonprofit called Cure Rare Disease...

Read Now

Team Led by Monkol Lek Advances Past Pre-IND Phase with DMD Gene Therapy

Duchenne Muscular Dystrophy (DMD) was first documented in the 1860s. More than a hundred years later, researchers discovered...

Read Now

Boston Globe: This founder is on a mission to use personalized therapeutics to save lives — including his brother’s

Rich Horgan created Cure Rare Disease (CRD) as a way to save his brother. Now, there are other lives at stake. CRD, a…

Read Now

News

Hope on the horizon

On Dec. 5, 2003, Ian Sharp was diagnosed with Becker muscular dystrophy. He was only 10 years old. From that day on, the Sharps, a local Aspen family, have been on a desperate search to find a cure for their son.

Read Now

Revolutionary genetic research could change the lives of those with rare diseases

NEW HAVEN, Conn. — Terry Horgan is a 26-year-old who works at Cornell University. He’s very tech savvy. Currently, he gets around in a motorized wheelchair due to a rare disease called Duchenne muscular dystrophy.Linda Horgan is Terry’s mother.“When we found out Terry had this, it’s like life left you," Linda said. "It’s like being in an elevator and it just drops.”Muscular dystrophy is characterized by the progression of muscle weakness throughout one’s life....

Read Now

Cornell Employee from Montour Falls to be First to Receive New Therapy for Rare Disorder

Terry Horgan, a Cornell graduate and now a Cornell employee, will be the first person in the world to undergo a possible cure for Duchenne muscular dystrophy. Horgan's brother Rich, also a Cornell graduate, is the founder and president of Cure Rare Diseases, the biotech nonprofit behind the treatment.

Read Now

Organization Looks To Help Families Impacted By Rare Diseases

Cure Rare Disease, a nonprofit biotechnology research organization, will hold a fundraising event on June 5 in Stamford.

Read Now

Hope on the Horizon for Branford Boy, 5, with debilitating, fatal disease

BRANFORD — Max Herzog, 51/2, was a “strapping boy” of almost 11 pounds at birth, so it was a shock for his parents to hear at about 6 months old that he had Duchenne muscular dystrophy, a rare disease that eventually would put him a wheelchair, then take his life.

Read Now

Forbes' "30 Under 30" List Highlights the Future Leaders of Biotech

Richard Horgan – 29-year-old Richard Horgan is the founder of Boston-based Cure Rare Disease, a non-profit biotech that develops custom-made drugs for rare diseases, including Duchenne muscular dystrophy. Horgan’s brother Terry is a DMD patient. Cure Rare Disease is currently working on a CRISPR-based therapeutic for this disease. The non-profit has raised about $2.3 million to conduct research on this drug, as well as others in its pipeline.

Read Now

Unconventional Life Show: Changing the World One Step at a Time With Cure Rare Disease Founder Rich Horgan

Ep269: Changing the World One Step at a Time, with Cure Rare Disease founder Rich Horgan

Read Now

Twitch Streamer, Esports Community Rally Behind Boston Entrepreneur Looking to Rure Brother’s Rare Muscle Condition

The gaming community is getting behind a Boston biotech entrepreneur’s quest to cure his younger brother’s rare genetic muscle condition. For the better part of his adult life, Rich Horgan has been working to fund a customized gene therapy designed specifically for his brother, Terry Horgan, who suffers from Duchenne muscular dystrophy, a rare inherited disease that causes significant muscle degeneration over time — and one that is fatal.

Read Now

The Mighty: How One Rare Disease Research Company Has Adapted to COVID-19

For many rare disease patients, the wait for treatment and research advancements can feel like a never-ending process. This wait is made…

Read Now

Rich Horgan Featured as a Business Insider’s 30 Under 40

As the US learned to handle surges in COVID-19 cases that overwhelmed hospitals and shut down cities and confronted systemic racism amid protests sparked by the police killing of George Floyd, healthcare leaders have been navigating a new reality.‍

Read Now

The Gamer: Rare Disease Organization Using Fortnite To Raise Money For Charity

An organization devoted to offering treatment to those diagnosed with rare genetic disorders, Cure Rare Disease (CRD), has announced a…

Read Now

Rich Horgan: “It’s all about the people you surround yourself with”

Leadership, to me, is defined as having the courage to imagine a better future and the conviction to not give up despite the challenge. No challenge worth solving is easy and it is a leader’s job to convince others to believe in the vision of a better tomorrow. Whether this is solving the problem of […]

Read Now

This founder is on a mission to use personalized therapeutics to save lives — including his brother’s

Rich Horgan’s Boston nonprofit is transforming the way we treat rare diseases.

Read Now

Custom CRISPR therapies could be closer than you think

Rich Horgan has assembled a team to quickly develop a gene-editing therapy for his brother’s rare form of muscular dystrophy. Other people with rare diseases hope they are next

Read Now